{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T14:45:06Z","timestamp":1773240306302,"version":"3.50.1"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure: European Journal of Epilepsy"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.seizure.2026.02.001","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T16:35:33Z","timestamp":1770050133000},"page":"18-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Lamotrigine as an antiseizure medication in pregnancy"],"prefix":"10.1016","volume":"136","author":[{"given":"Frank J.E.","family":"Vajda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7198-8621","authenticated-orcid":false,"given":"Terence J.","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2140-2351","authenticated-orcid":false,"given":"Janet E.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3611-8819","authenticated-orcid":false,"given":"Alison E.","family":"Hitchcock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piero","family":"Perucca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilie M.","family":"Lander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mervyn J.","family":"Eadie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.seizure.2026.02.001_bib0001","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1479-828X.2007.00781.x","article-title":"The Australian register of antiepileptic drugs in pregnancy: the first 1002 pregnancies","volume":"47","author":"Vajda","year":"2007","journal-title":"Aust N Z J Obs Gynaecol"},{"issue":"12","key":"10.1016\/j.seizure.2026.02.001_bib0002","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/j.jocn.2010.05.008","article-title":"The Australian pregnancy register of anti-epileptic drugs: 10 years of progress","volume":"17","author":"Vajda","year":"2010","journal-title":"J Clin Neurosci"},{"issue":"9","key":"10.1016\/j.seizure.2026.02.001_bib0003","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.jocn.2013.11.049","article-title":"The Australian register of antiepileptic drugs in pregnancy: changes over time in the epileptic population","volume":"21","author":"Vajda","year":"2014","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.seizure.2026.02.001_bib0004","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.yebeh.2018.04.009","article-title":"Changes in antiepileptic drug-prescribing patterns in pregnant women with epilepsy","volume":"84","author":"Meador","year":"2018","journal-title":"Epilepsy Behav"},{"issue":"8","key":"10.1016\/j.seizure.2026.02.001_bib0005","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1517\/14656566.2012.665875","article-title":"Lamotrigine use in pregnancy","volume":"13","author":"Moore","year":"2012","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.seizure.2026.02.001_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2024.109924","article-title":"Seizure control and adverse outcomes of lamotrigine use during pregnancy: a systematic review and meta-analysis","volume":"157","author":"Wan","year":"2024","journal-title":"Epilepsy Behav"},{"issue":"6","key":"10.1016\/j.seizure.2026.02.001_bib0007","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s40263-017-0433-0","article-title":"Pregnancy Outcomes Following In Utero Exposure to Lamotrigine: A Systematic Review and Meta-Analysis","volume":"31","author":"Pariente","year":"2017","journal-title":"CNS Drugs"},{"issue":"22","key":"10.1016\/j.seizure.2026.02.001_bib0008","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1212\/01.wnl.0000289511.20864.2a","article-title":"Lamotrigine in pregnancy: clearance, therapeutic drug monitoring, and seizure frequency","volume":"70","author":"Pennell","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2026.02.001_bib0009","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.eplepsyres.2018.01.011","article-title":"UGT polymorphisms and lamotrigine clearance during pregnancy","volume":"140","author":"Petrenaite","year":"2018","journal-title":"Epilepsy Res"},{"issue":"2\u20133","key":"10.1016\/j.seizure.2026.02.001_bib0010","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.eplepsyres.2003.09.008","article-title":"Evaluation of VPA dose and concentration effects on lamotrigine pharmacokinetics: implications for conversion to lamotrigine monotherapy","volume":"57","author":"Gidal","year":"2003","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2026.02.001_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2025.107554","article-title":"UGT polymorphisms and epileptic seizure control in pregnant women treated with Lamotrigine","volume":"213","author":"Hansen","year":"2025","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2026.02.001_bib0012","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.eplepsyres.2018.01.011","article-title":"UGT polymorphisms and lamotrigine clearance during pregnancy","volume":"140","author":"Petrenaite","year":"2018","journal-title":"Epilepsy Res"},{"issue":"22","key":"10.1016\/j.seizure.2026.02.001_bib0013","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1212\/01.wnl.0000289511.20864.2a","article-title":"Lamotrigine in pregnancy: clearance, therapeutic drug monitoring, and seizure frequency","volume":"70","author":"Pennell","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2026.02.001_bib0014","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ejogrb.2013.10.021","article-title":"Effects of monitoring strategies on seizures in pregnant women on lamotrigine: a meta-analysis","volume":"172","author":"Pirie","year":"2014","journal-title":"Eur J Obs Gynecol Reprod Biol"},{"issue":"9","key":"10.1016\/j.seizure.2026.02.001_bib0015","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1111\/j.1528-1167.2009.02166.x","article-title":"Seizure frequency in pregnant women treated with lamotrigine monotherapy","volume":"50","author":"Sabers","year":"2009","journal-title":"Epilepsia"}],"container-title":["Seizure: European Journal of Epilepsy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131126000294?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131126000294?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T19:04:55Z","timestamp":1773169495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131126000294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":15,"alternative-id":["S1059131126000294"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2026.02.001","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lamotrigine as an antiseizure medication in pregnancy","name":"articletitle","label":"Article Title"},{"value":"Seizure: European Journal of Epilepsy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2026.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd on behalf of British Epilepsy Association.","name":"copyright","label":"Copyright"}]}}